Bibliographie - 2057 - Stabilis 4.0

viimane versioon :
19/11/2024

Viited

Viited 2057

tüüp :

ajaleht

uurimisrühmad :

Stevenage - Lister Hospital, Quality Control Laboratory

Autor :

Droste JC, Jeraj HA, MacDonald A, Farrington K.

pealkiri :

Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.

publikatsioon :

J Antimicrob Chemother ; 51: 849-855. 2003

Tõendite tase :

AideBibliographie

füüsikaline stabiilsus :

Keemiline püsivus :

Muud meetodid :

Kommentaarid :

ingredientide nimekiri

Süsteravim

Ciprofloxacin lactate

antibiootikum

	0.4 & 0.6 mg/ml	+ Heparin sodium	10 >> 1000 UI/ml	+
	0.8 mg/ml	+ Heparin sodium	10 >> 5000 UI/ml	+
	1 mg/ml	+ Heparin sodium	10 >> 10000 UI/ml	+
	0.8 mg/ml	+ Heparin sodium	10000 UI/ml	+
	0.4 & 0.6 mg/ml	+ Heparin sodium	5000 & 10000 UI/ml	+
	0.2 mg/ml	+ Heparin sodium	1000 >> 10000 UI/ml	+
	0.1 mg/ml	+ Heparin sodium	10 >> 10000 UI/ml	+
	0.2 mg/ml	+ Heparin sodium	10 & 100 UI/ml	+

Süsteravim

antikoagulant

	10 >> 1000 UI/ml	+ Ciprofloxacin lactate	0.4 & 0.6 mg/ml	+
	10 >> 5000 UI/ml	+ Ciprofloxacin lactate	0.8 mg/ml	+
	10 >> 10000 UI/ml	+ Ciprofloxacin lactate	1 mg/ml	+
	10000 UI/ml	+ Ciprofloxacin lactate	0.8 mg/ml	+
	5000 & 10000 UI/ml	+ Ciprofloxacin lactate	0.4 & 0.6 mg/ml	+
	1000 >> 10000 UI/ml	+ Ciprofloxacin lactate	0.2 mg/ml	+
	10 >> 10000 UI/ml	+ Ciprofloxacin lactate	0.1 mg/ml	+
	10 & 100 UI/ml	+ Ciprofloxacin lactate	0.2 mg/ml	+
	10 >> 10000 UI/ml	+ Linezolid	0.2 >> 1.92 mg/ml	+
	10 >> 10000 UI/ml	+ Teicoplanine	0.02 >> 10 mg/ml	+

Süsteravim

Linezolid

antibiootikum

Ühilduv

0.2 >> 1.92 mg/ml

+

Süsteravim

Heparin sodium

10 >> 10000 UI/ml

+

naatriumkloriid 0.9%

Süsteravim

Teicoplanine

antibiootikum

Ühilduv

0.02 >> 10 mg/ml

+

Süsteravim

Heparin sodium

10 >> 10000 UI/ml

+

naatriumkloriid 0.9%

Mentions Légales